US stocks were mixed on Thursday in anticipation of Amazon's quarterly results, as investors assessed the earnings season so ...
US stocks were mixed on Thursday in anticipation of Amazon's quarterly results, as investors assessed the earnings season so far and eyed President Donald Trump's fast-moving poli ...
22h
Hosted on MSNStocks Find Support From Strong Earnings ResultsThe S&P 500 Index ($SPX) (SPY) today is up +0.29%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.12%, and the Nasdaq ...
21h
Barchart on MSNStocks See Support from Positive Earnings ResultsReal-time index price for Nasdaq Transportation Index (NAST), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
EST Cathie Wood’s ARK Investment buys 54.4K shares of Qualcomm (QCOM) todayMaximize Your Portfolio with Data Driven Insights:Leverage the ...
Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
Weight loss drugs are huge these days, and Eli Lilly (LLY) is leading the pack when it comes to these. However, today’s ...
Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...
1h
Hosted on MSNWe Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug WarsShares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...
21hon MSN
Eli Lilly reported mixed fourth-quarter results on Thursday, surpassing earnings expectations but falling short of sales projections, even as demand for its flagship weight loss drug Zepbound and ...
Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results